Breaking News
23 hours ago
Vaibhavi M.

Medera's DMC clears MUSIC-HFpEF trial to advance without protocol changes, opening the path to FDA discussions on the next randomized stage.
Vaibhavi M.

ImmuPharma selects Bachem AG as API manufacturing partner for Kapiglucagon, marking a key CMC milestone ahead of IND-enabling activities.
Vaibhavi M.

ProQR's Phase 1 AX-0810 data confirm first clinical validation of the Axiomer RNA editing platform, with dose-dependent NTCP target engagement.
Vaibhavi M.

Intas Pharmaceuticals names Girish Bhunje SVP – API Operations, reinforcing executive-level GMP and supply chain leadership.
Vaibhavi M.
